Medovex Corp Stock Probability Of Bankruptcy
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Medovex |
Medovex Corp OTC Stock probability of financial unrest Analysis
Medovex Corp's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Medovex Corp Probability Of Bankruptcy | Over 100% |
Most of Medovex Corp's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Medovex Corp probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Medovex Corp odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Medovex Corp financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Medovex Corp has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Healthcare sector and 82.35% higher than that of the Biotechnology industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Medovex Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in probability of bankruptcy category among its peers.
Medovex Fundamentals
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 | |||
| Operating Margin | (3.51) % | |||
| Current Valuation | 8.88 M | |||
| Shares Outstanding | 477.61 K | |||
| Shares Owned By Insiders | 25.51 % | |||
| Number Of Shares Shorted | 294 | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 34.90 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 906.81 K | |||
| EBITDA | (4.61 M) | |||
| Net Income | (4.8 M) | |||
| Cash And Equivalents | 45.88 K | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 2.61 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (17.98) X | |||
| Cash Flow From Operations | (4.81 M) | |||
| Short Ratio | 3.47 X | |||
| Earnings Per Share | (0.05) X | |||
| Target Price | 1.75 | |||
| Beta | 0.73 | |||
| Market Capitalization | 1.06 M | |||
| Total Asset | 321.4 K | |||
| Retained Earnings | (38.35 M) | |||
| Working Capital | 3.33 M | |||
| Current Asset | 4.18 M | |||
| Current Liabilities | 851.22 K | |||
| Net Asset | 321.4 K |
About Medovex Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medovex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medovex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medovex Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |